Skip to content
PICO Portalanswers from OpenAlex

When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients?

PaperCitations, authors & open-access status

When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients? is a paper indexed in PICO Portal from OpenAlex.

How many citations does When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients? have?

PICO Portalcitation count

When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients? has 13 citations in the OpenAlex counts PICO Portal stores.

When was When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients? published?

PICO Portalyear

When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients? has 2023 year in the PICO Portal index.

What is the open-access status of When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients??

PICO Portaloa status

When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients? has hybrid oa status in the PICO Portal index.

What is the DOI of When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients??

PICO Portaldoi

The DOI for When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients? is on the source record.

What is the PMID of When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients??

PICO Portalpmid

The PMID for When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients? is on the source record.

What is the OpenAlex record for When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients??

PICO Portalopenalex

The OpenAlex for When should targeted therapies be used in the treatment of lupus nephritis: Early in the disease course or in refractory patients? is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial